Cargando…

Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats

AIM: The current investigation focused on the therapeutic role of the administration of taurine on hypertensive rats to reduce or cure the hazard effects of hypertension problems. METHODOLOGY: This research included 2 experiments; 1(st) was done to survey the variations that might occur in blood pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Marwan A., Eraqi, Mostafa M., Alfaiz, Faiz A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970174/
https://www.ncbi.nlm.nih.gov/pubmed/31989053
http://dx.doi.org/10.1016/j.heliyon.2020.e03209
_version_ 1783489462946234368
author Ibrahim, Marwan A.
Eraqi, Mostafa M.
Alfaiz, Faiz A.
author_facet Ibrahim, Marwan A.
Eraqi, Mostafa M.
Alfaiz, Faiz A.
author_sort Ibrahim, Marwan A.
collection PubMed
description AIM: The current investigation focused on the therapeutic role of the administration of taurine on hypertensive rats to reduce or cure the hazard effects of hypertension problems. METHODOLOGY: This research included 2 experiments; 1(st) was done to survey the variations that might occur in blood pressure (BP) of male rats because of the fed 8% NaCl diet for 4 weeks. 2(nd) experiment, it contains normal control rats', hypertensive rats were served as hypertension recovery group and hypertensive rats were took orally by the help of gastric tube 50 mg taurine/100 g b.wt/day for four weeks and served as taurine group. RESULTS: 1(st) experimental, clarified a significant elevation in BP, body weight, serum cholesterol, triglycerides, LDL, activities of serum cardiac enzymes, endothelin-1, ADMA, MDA and TNF-α in hypertensive rats' group. On contrary, there is a significant reduction in serum level of TNO and antioxidant enzymes level in relation to the control group. A numerical variation but not statistically significant was happened in HDL in hypertensive rats' group as compared to their matching results in control rats' group. 2(nd) experimental taurine significantly reduced the BP as compared with hypertensive control. Furthermore, a significant improvement occurred in the mean value of most investigation parameters in hypertensive animal group which treated with taurine. CONCLUSION: The previous data could be concluded that, there is an obvious amelioration effects of taurine on hypertensive rats by reducing the hazard effects of hypertension problems. The primary mechanisms were discussed according to existing published investigations.
format Online
Article
Text
id pubmed-6970174
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69701742020-01-27 Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats Ibrahim, Marwan A. Eraqi, Mostafa M. Alfaiz, Faiz A. Heliyon Article AIM: The current investigation focused on the therapeutic role of the administration of taurine on hypertensive rats to reduce or cure the hazard effects of hypertension problems. METHODOLOGY: This research included 2 experiments; 1(st) was done to survey the variations that might occur in blood pressure (BP) of male rats because of the fed 8% NaCl diet for 4 weeks. 2(nd) experiment, it contains normal control rats', hypertensive rats were served as hypertension recovery group and hypertensive rats were took orally by the help of gastric tube 50 mg taurine/100 g b.wt/day for four weeks and served as taurine group. RESULTS: 1(st) experimental, clarified a significant elevation in BP, body weight, serum cholesterol, triglycerides, LDL, activities of serum cardiac enzymes, endothelin-1, ADMA, MDA and TNF-α in hypertensive rats' group. On contrary, there is a significant reduction in serum level of TNO and antioxidant enzymes level in relation to the control group. A numerical variation but not statistically significant was happened in HDL in hypertensive rats' group as compared to their matching results in control rats' group. 2(nd) experimental taurine significantly reduced the BP as compared with hypertensive control. Furthermore, a significant improvement occurred in the mean value of most investigation parameters in hypertensive animal group which treated with taurine. CONCLUSION: The previous data could be concluded that, there is an obvious amelioration effects of taurine on hypertensive rats by reducing the hazard effects of hypertension problems. The primary mechanisms were discussed according to existing published investigations. Elsevier 2020-01-17 /pmc/articles/PMC6970174/ /pubmed/31989053 http://dx.doi.org/10.1016/j.heliyon.2020.e03209 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ibrahim, Marwan A.
Eraqi, Mostafa M.
Alfaiz, Faiz A.
Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_full Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_fullStr Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_full_unstemmed Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_short Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
title_sort therapeutic role of taurine as antioxidant in reducing hypertension risks in rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970174/
https://www.ncbi.nlm.nih.gov/pubmed/31989053
http://dx.doi.org/10.1016/j.heliyon.2020.e03209
work_keys_str_mv AT ibrahimmarwana therapeuticroleoftaurineasantioxidantinreducinghypertensionrisksinrats
AT eraqimostafam therapeuticroleoftaurineasantioxidantinreducinghypertensionrisksinrats
AT alfaizfaiza therapeuticroleoftaurineasantioxidantinreducinghypertensionrisksinrats